Pia van der Zee

Sysmex Europe GmbH designs and produces diagnostic solutions for medical laboratories. It offers diagnostics for haematology, urinalysis, coagulation, moleculat siagnostics, digital imaging, reagent production and veterinary solutions. It also provides solutions for optimized cancer management, sentinel lymph node analysis, and localization, patient care, faecal immunochemical test for haemoglobin, digital pathology and blood-based molecular testing. The company was founded in 1980 and is headquartered in Nordertstedt, Germany.

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.

ArcDia International Oy Ltd. manufactures smart grid inverters. The firm's mariAST and mariPOC platforms are based on the proprietary ArcDia TPX detection technology. Its TPX technology allows multianalyte rapid testing with fully automated and random-access test system. The company was founded by Aleksi Soini in 2008 and is headquartered in Turku, Finland.

Part of Biocartis Group NV, Biocartis NV is a Belgian molecular diagnostics company that aims to revolutionize the field with its proprietary IdyllaTM platform. The company is based in Mechelen, Belgium, and the CEO of the company is Herman Verrelst. The company provides next-generation diagnostic solutions with a focus on improving clinical practice in oncology for the benefit of patients, clinicians, payers, and the healthcare industry.